Informations générales (source: ClinicalTrials.gov)

NCT05057559 Active, sans recrutement
Prospective, Observational, Open-label, Clinical Investigation of Intra-articular Arthrosamid® Injection in Subjects With Knee Osteoarthritis
Observational
  • Arthrose
  • Gonarthrose
avril 2021
janvier 2029
20 septembre 2026
This is a prospective, long-term, observational, all-comers, open-label, multi-centre clinical investigation enrolling subjects with knee osteoarthritis who is eligible for treatment with Arthrosamid® according to the Instruction for Use.
 Voir le détail

Etablissements

Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
AP-HM hopitaux - Marseille - France Contact (sur clinicalTrials)
Clinique Saint Louis - Poissy - France Contact (sur clinicalTrials)

Critères

Tous


- Stated willingness to comply with all study procedures and availability for the
duration of the study

- Male or female, aged ≥ 18 years

- Clinical diagnosis of knee OA

Exclusion Criteria:


- If an active skin disease or infection is present at or near the injection site

- If the joint is infected or severely inflamed

- If a degradable intra-articular injectable such as hyaluronic acid is present, it
must be expected to be absorbed according to manufacturer's information for the
specific product, before injection with Arthrosamid®

- If the patient has previously received treatment with a different non-absorbable
injectable/implant

- If the patient has received a knee alloplasty or has any foreign material in the
knee

- If the patient has undergone knee arthroscopy within the last 6 months

- If the patient has haemophilia or is in uncontrolled anticoagulant treatment